Results 271 to 280 of about 67,560 (281)

The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia

European Urology, 2013
Stefan Ückert, Mario Maggi
exaly  

Phosphodiesterase 5 inhibitors: current status and potential applications

Nature Reviews Drug Discovery, 2002
exaly  

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma

JAMA - Journal of the American Medical Association, 2015
Stacy Loeb, Yasin Folkvaljon, Mats P Lambe   +2 more
exaly  

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

Lancet, The, 2005
exaly  

DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN

Lancet, The, 1978
exaly  

Phosphodiesterase Inhibitors for Pulmonary Hypertension

New England Journal of Medicine, 2010
exaly  

Elucidation of Phosphodiesterase Type 5 Inhibitor Mechanism of Action

Journal of Urology, 2013
openaire   +2 more sources

Phosphodiesterase type 5 inhibitor therapy for priapism

2008
openaire   +1 more source

Identification, Characterization, and Functional Role of Phosphodiesterase Type IV in Cerebral Vessels: Effects of Selective Phosphodiesterase Inhibitors

Journal of Cerebral Blood Flow and Metabolism, 1997
exaly  

Tadalafil: Long-acting phosphodiesterase type 5 inhibitor

2008
openaire   +1 more source